SynthesisFrontiers in reproductive health2026
Platelet-rich plasma and folliculogenesis: a systematic mechanistic review and computational pathway analysis.
Synthesis in Frontiers in reproductive health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Platelet-rich plasma (PRP) has been proposed as a potential intervention for promoting ovarian follicular development. However, its underlying biological mechanisms remain unclear. This study investigated whether the mechanisms through which PRP may influence follicular development are consistent with previously established regulatory mechanisms of human folliculogenesis. Methods: A systems biology approach was used to examine the mechanistic relationships between growth factors present in PRP and known regulators of human follicular development. Gene databases were compared, and pathway enrichment analysis and integrated network modeling were performed to identify shared signaling pathways and patterns of molecular connectivity. Results: Although there was limited overlap between the two gene databases, substantial convergence was observed in pathway enrichment and integrated network modeling. This convergence involved receptor tyrosine kinase-centered intracellular signaling pathways, particularly the PI3K-AKT and MAPK pathways. Network topology demonstrated coherent connectivity between extracellular growth factors and established survival and proliferation signaling axes. However, no overlap was identified between genes associated with PRP and genes encoding oocyte-specific transcriptional regulators involved in primordial follicle formation and differentiation. Discussion: These findings support a model in which PRP does not replace the endogenous transcriptional program governing follicular development. Instead, PRP may increase upstream growth factor signaling and enhance intrinsic survival and proliferation pathways within the ovarian microenvironment. This systems-level framework provides mechanistic insight into the biological plausibility of PRP use in reproductive medicine and offers a rational basis for targeted experimental validation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.